New board appointment at Cellceutix
This article was originally published in Scrip
Executive Summary
Dr Emil Frei is to serve on Cellceutix's scientific advisory board until June 30th, 2010. Dr Frei, a leading oncologist, has served in several leadership positions including chief of medicine at the National Cancer Institute, associate scientific director at MD Anderson and director and physician-in-chief at the Dana-Farber Cancer Institute. He continues to serve as physician-in-chief, emeritus, at Dana-Farber.